During the past decade, K. Dluski Hospital-Medical Academy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "K. Dluski Hospital-Medical Academy" #1 collaborator was "Lymphoma Trials Office" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "K. Dluski Hospital-Medical Academy" are "Lung Cancer" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "K. Dluski Hospital-Medical Academy" in a lesser frequency.

Most popular intervention types in "K. Dluski Hospital-Medical Academy" are "Drug" (2 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (2 trials), "bone marrow ablation with stem cell support" (1 trials), "carmustine" (1 trials), "cisplatin" (1 trials) and "cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "K. Dluski Hospital-Medical Academy" are 2 trials for "All" genders.

Currently, there are NaN active trials in "K. Dluski Hospital-Medical Academy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in K. Dluski Hospital-Medical Academy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in K. Dluski Hospital-Medical Academy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".